Klotho Therapeutics, Inc.
PrivateLast Round
Series A
Nov 2, 2017
Total Funding Raised
$10M
Company Overview
Klotho Therapeutics, Inc. is a biotechnology company that develops patent-pending recombinant versions of the human Klotho protein to treat age-related diseases such as kidney disease, cognitive decline, and cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Klotho Therapeutics, Inc. Comparables
Compare Klotho Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Jocasta Neuroscience | 85% | |
| ADvantage Therapeutics Inc. | 83% | |
| Elevian | 79% | |
Klotho Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 2, 2017 |
Klotho Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Thynk Capital | Series A |
Klotho Therapeutics, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Klotho Therapeutics, Inc.'s valuation, stock price, and market status.